APO RESEARCH · REPORT
Hydroxychloroquine Sulphate
Hydroxychloroquine sulfate was listed in the United States in 1955 and used in malaria, rheumatoid arthritis and lupus erythematosus. The variety has been approved in more than 70 countries such as Canada, France, Germany, Australia, China, Japan, etc.
Product & engineering
Understand the product.
Hydroxychloroquine sulfate was listed in the United States in 1955 and used in malaria, rheumatoid arthritis and lupus erythematosus. The variety has been approved in more than 70 countries such as Canada, France, Germany, Australia, China, Japan, etc.
Hydroxychloroquine sulfate, initially an anti malarial drug, was found to have mild immunosuppressive and immunomodulatory effects in clinical practice.
Selected research
Industry Growth & Trends
Global Hydroxychloroquine Sulphate Industry Growth and Trends Forecast to 2032
Market perspective
Hydroxychloroquine sulfate was listed in the United States in 1955 and used in malaria, rheumatoid arthritis and lupus erythematosus. The variety has been approved in more than 70 countries such as Canada, France, Germany, Australia, China, Japan, etc.
Hydroxychloroquine sulfate, initially an anti malarial drug, was found to have mild immunosuppressive and immunomodulatory effects in clinical practice.
The major producers in the industry are Sanofi, Novartis and Shanghai Zhongxisanwei, with their revenue ratios of 36.07%, 14.20% and 15.08% respectively in 2019.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Hydroxychloroquine Sulphate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Hydroxychloroquine Sulphate market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hydroxychloroquine Sulphate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hydroxychloroquine Sulphate.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Hydroxychloroquine Sulphate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Hydroxychloroquine Sulphate Market by Company
Sanofi
Novartis
Shanghai Zhongxisanwei
Teva
Zydus Cadila
Mylan
Apotex
Advanz Pharma
Sun Pharma
Kyung Poong
Ipca Laboratories
Hanlim Pharmaceutical
Bristol Laboratories
Hydroxychloroquine Sulphate Segment by Type
100mg
200mg
Others
Hydroxychloroquine Sulphate Segment by Application
Lupus Erythematosus
Rheumatoid Arthritis
Others
Hydroxychloroquine Sulphate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxychloroquine Sulphate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydroxychloroquine Sulphate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxychloroquine Sulphate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hydroxychloroquine Sulphate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Hydroxychloroquine Sulphate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 100mg
- 200mg
- Others
Applications
- Lupus Erythematosus
- Rheumatoid Arthritis
- Others
Companies covered
- Sanofi
- Novartis
- Shanghai Zhongxisanwei
- Teva
- Zydus Cadila
- Mylan
- Apotex
- Advanz Pharma
- Sun Pharma
- Kyung Poong
- Ipca Laboratories
- Hanlim Pharmaceutical
- Bristol Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Hydroxychloroquine Sulphate Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Hydroxychloroquine Sulphate Sales Estimates and Forecasts (2021-2032)
- 1.3 Hydroxychloroquine Sulphate Market by Type
- 1.3.1 100mg
- 1.3.2 200mg
- 1.3.3 Others
- 1.4 Global Hydroxychloroquine Sulphate Market Size by Type
- 1.4.1 Global Hydroxychloroquine Sulphate Market Size Overview by Type (2021-2032)
- 1.4.2 Global Hydroxychloroquine Sulphate Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Hydroxychloroquine Sulphate Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Hydroxychloroquine Sulphate Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Hydroxychloroquine Sulphate Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Hydroxychloroquine Sulphate Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Hydroxychloroquine Sulphate Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Hydroxychloroquine Sulphate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Hydroxychloroquine Sulphate Industry Trends
- 2.2 Hydroxychloroquine Sulphate Industry Drivers
- 2.3 Hydroxychloroquine Sulphate Industry Opportunities and Challenges
- 2.4 Hydroxychloroquine Sulphate Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Hydroxychloroquine Sulphate Revenue (2021-2026)
- 3.2 Global Top Players by Hydroxychloroquine Sulphate Sales (2021-2026)
- 3.3 Global Top Players by Hydroxychloroquine Sulphate Price (2021-2026)
- 3.4 Global Hydroxychloroquine Sulphate Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hydroxychloroquine Sulphate Major Company Production Sites & Headquarters
- 3.6 Global Hydroxychloroquine Sulphate Company, Product Type & Application
- 3.7 Global Hydroxychloroquine Sulphate Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hydroxychloroquine Sulphate Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hydroxychloroquine Sulphate Players Market Share by Revenue in 2025
- 3.8.3 2025 Hydroxychloroquine Sulphate Tier 1, Tier 2, and Tier 3
4 Hydroxychloroquine Sulphate Regional Status and Outlook
- 4.1 Global Hydroxychloroquine Sulphate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Hydroxychloroquine Sulphate Historic Market Size by Region
- 4.2.1 Global Hydroxychloroquine Sulphate Sales in Volume by Region (2021-2026)
- 4.2.2 Global Hydroxychloroquine Sulphate Sales in Value by Region (2021-2026)
- 4.2.3 Global Hydroxychloroquine Sulphate Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Hydroxychloroquine Sulphate Forecasted Market Size by Region
- 4.3.1 Global Hydroxychloroquine Sulphate Sales in Volume by Region (2027-2032)
- 4.3.2 Global Hydroxychloroquine Sulphate Sales in Value by Region (2027-2032)
- 4.3.3 Global Hydroxychloroquine Sulphate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hydroxychloroquine Sulphate by Application
- 5.1 Hydroxychloroquine Sulphate Market by Application
- 5.1.1 Lupus Erythematosus
- 5.1.2 Rheumatoid Arthritis
- 5.1.3 Others
- 5.2 Global Hydroxychloroquine Sulphate Market Size by Application
- 5.2.1 Global Hydroxychloroquine Sulphate Market Size Overview by Application (2021-2032)
- 5.2.2 Global Hydroxychloroquine Sulphate Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Hydroxychloroquine Sulphate Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Hydroxychloroquine Sulphate Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Hydroxychloroquine Sulphate Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Hydroxychloroquine Sulphate Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Hydroxychloroquine Sulphate Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Hydroxychloroquine Sulphate Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Sanofi
- 6.1.1 Sanofi Company Information
- 6.1.2 Sanofi Business Overview
- 6.1.3 Sanofi Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Sanofi Hydroxychloroquine Sulphate Product Portfolio
- 6.1.5 Sanofi Recent Developments
- 6.2 Novartis
- 6.2.1 Novartis Company Information
- 6.2.2 Novartis Business Overview
- 6.2.3 Novartis Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Novartis Hydroxychloroquine Sulphate Product Portfolio
- 6.2.5 Novartis Recent Developments
- 6.3 Shanghai Zhongxisanwei
- 6.3.1 Shanghai Zhongxisanwei Company Information
- 6.3.2 Shanghai Zhongxisanwei Business Overview
- 6.3.3 Shanghai Zhongxisanwei Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Shanghai Zhongxisanwei Hydroxychloroquine Sulphate Product Portfolio
- 6.3.5 Shanghai Zhongxisanwei Recent Developments
- 6.4 Teva
- 6.4.1 Teva Company Information
- 6.4.2 Teva Business Overview
- 6.4.3 Teva Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Teva Hydroxychloroquine Sulphate Product Portfolio
- 6.4.5 Teva Recent Developments
- 6.5 Zydus Cadila
- 6.5.1 Zydus Cadila Company Information
- 6.5.2 Zydus Cadila Business Overview
- 6.5.3 Zydus Cadila Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Zydus Cadila Hydroxychloroquine Sulphate Product Portfolio
- 6.5.5 Zydus Cadila Recent Developments
- 6.6 Mylan
- 6.6.1 Mylan Company Information
- 6.6.2 Mylan Business Overview
- 6.6.3 Mylan Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Mylan Hydroxychloroquine Sulphate Product Portfolio
- 6.6.5 Mylan Recent Developments
- 6.7 Apotex
- 6.7.1 Apotex Company Information
- 6.7.2 Apotex Business Overview
- 6.7.3 Apotex Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Apotex Hydroxychloroquine Sulphate Product Portfolio
- 6.7.5 Apotex Recent Developments
- 6.8 Advanz Pharma
- 6.8.1 Advanz Pharma Company Information
- 6.8.2 Advanz Pharma Business Overview
- 6.8.3 Advanz Pharma Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Advanz Pharma Hydroxychloroquine Sulphate Product Portfolio
- 6.8.5 Advanz Pharma Recent Developments
- 6.9 Sun Pharma
- 6.9.1 Sun Pharma Company Information
- 6.9.2 Sun Pharma Business Overview
- 6.9.3 Sun Pharma Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Sun Pharma Hydroxychloroquine Sulphate Product Portfolio
- 6.9.5 Sun Pharma Recent Developments
- 6.10 Kyung Poong
- 6.10.1 Kyung Poong Company Information
- 6.10.2 Kyung Poong Business Overview
- 6.10.3 Kyung Poong Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Kyung Poong Hydroxychloroquine Sulphate Product Portfolio
- 6.10.5 Kyung Poong Recent Developments
- 6.11 Ipca Laboratories
- 6.11.1 Ipca Laboratories Company Information
- 6.11.2 Ipca Laboratories Business Overview
- 6.11.3 Ipca Laboratories Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Ipca Laboratories Hydroxychloroquine Sulphate Product Portfolio
- 6.11.5 Ipca Laboratories Recent Developments
- 6.12 Hanlim Pharmaceutical
- 6.12.1 Hanlim Pharmaceutical Company Information
- 6.12.2 Hanlim Pharmaceutical Business Overview
- 6.12.3 Hanlim Pharmaceutical Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Hanlim Pharmaceutical Hydroxychloroquine Sulphate Product Portfolio
- 6.12.5 Hanlim Pharmaceutical Recent Developments
- 6.13 Bristol Laboratories
- 6.13.1 Bristol Laboratories Company Information
- 6.13.2 Bristol Laboratories Business Overview
- 6.13.3 Bristol Laboratories Hydroxychloroquine Sulphate Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Bristol Laboratories Hydroxychloroquine Sulphate Product Portfolio
- 6.13.5 Bristol Laboratories Recent Developments
7 North America by Country
- 7.1 North America Hydroxychloroquine Sulphate Sales by Country
- 7.1.1 North America Hydroxychloroquine Sulphate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Hydroxychloroquine Sulphate Sales by Country (2021-2026)
- 7.1.3 North America Hydroxychloroquine Sulphate Sales Forecast by Country (2027-2032)
- 7.2 North America Hydroxychloroquine Sulphate Market Size by Country
- 7.2.1 North America Hydroxychloroquine Sulphate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Hydroxychloroquine Sulphate Market Size by Country (2021-2026)
- 7.2.3 North America Hydroxychloroquine Sulphate Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Hydroxychloroquine Sulphate Sales by Country
- 8.1.1 Europe Hydroxychloroquine Sulphate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Hydroxychloroquine Sulphate Sales by Country (2021-2026)
- 8.1.3 Europe Hydroxychloroquine Sulphate Sales Forecast by Country (2027-2032)
- 8.2 Europe Hydroxychloroquine Sulphate Market Size by Country
- 8.2.1 Europe Hydroxychloroquine Sulphate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Hydroxychloroquine Sulphate Market Size by Country (2021-2026)
- 8.2.3 Europe Hydroxychloroquine Sulphate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Hydroxychloroquine Sulphate Sales by Country
- 9.1.1 Asia-Pacific Hydroxychloroquine Sulphate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Hydroxychloroquine Sulphate Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Hydroxychloroquine Sulphate Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Hydroxychloroquine Sulphate Market Size by Country
- 9.2.1 Asia-Pacific Hydroxychloroquine Sulphate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Hydroxychloroquine Sulphate Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Hydroxychloroquine Sulphate Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Hydroxychloroquine Sulphate Sales by Country
- 10.1.1 South America Hydroxychloroquine Sulphate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Hydroxychloroquine Sulphate Sales by Country (2021-2026)
- 10.1.3 South America Hydroxychloroquine Sulphate Sales Forecast by Country (2027-2032)
- 10.2 South America Hydroxychloroquine Sulphate Market Size by Country
- 10.2.1 South America Hydroxychloroquine Sulphate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Hydroxychloroquine Sulphate Market Size by Country (2021-2026)
- 10.2.3 South America Hydroxychloroquine Sulphate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Hydroxychloroquine Sulphate Sales by Country
- 11.1.1 Middle East and Africa Hydroxychloroquine Sulphate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Hydroxychloroquine Sulphate Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Hydroxychloroquine Sulphate Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Hydroxychloroquine Sulphate Market Size by Country
- 11.2.1 Middle East and Africa Hydroxychloroquine Sulphate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Hydroxychloroquine Sulphate Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Hydroxychloroquine Sulphate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Hydroxychloroquine Sulphate Value Chain Analysis
- 12.1.1 Hydroxychloroquine Sulphate Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Hydroxychloroquine Sulphate Production Mode & Process
- 12.2 Hydroxychloroquine Sulphate Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Hydroxychloroquine Sulphate Distributors
- 12.2.3 Hydroxychloroquine Sulphate Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst